Bill Snyder

The discovery, reported in the journal PLOS Pathogens, could help open the door to the development of effective vaccines and antibody therapies with an “exceptional breadth of pathogen coverage.”

Lucy Spalluto, MD, MPH, and Jennifer Lewis, MD, MS, MPH, are the recipients of the 2024 VAQS Team Award for work they began in 2017.

Developed in the wake of the COVID-19 pandemic, ReVAMPP will support a coordinating center and seven research centers, including VUMC, with a focus on nine virus groups that pose the greatest risk to human health.

The awards honor staff members who provide exemplary support at all levels across the research enterprise. Their contributions to research are unmatched and invaluable to the science conducted at Vanderbilt.

The subject of his Discovery Lecture, which will begin at 4 p.m. Sept. 26 in 208 Light Hall, is the role of ribosomes in initiating the translation of DNA into RNA, a precursor step to transcribing the genetic code into proteins that do the work of the cell.

VUMC researchers found that peptides modified by highly reactive compounds called isolevuglandins activated T cells and promoted hypertension in mice. Their first-ever isolation of such peptides is a step toward potentially intervening in this pathologic process.